Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against Neuroblastoma.
Rosa NguyenXiyuan ZhangMing SunShahroze AbbasCharlie SeibertMichael C KellyJack F ShernCarol J ThielePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Hu14.18-IL15 and Hu14.18-IL21 exhibit robust preclinical activity, warranting further consideration for clinical testing in patients with GD2-expressing neuroblastoma.